Spectroscopic insights with molecular docking and molecular dynamic simulation studies of anticancer drug 5-fluororouracil targeting human pyruvate kinase m2

• Published in: Journal of biomolecular structure & dynamics 2024-02, p.1
• Main Authors: Priyadarshinee, Mamali, Dehury, Budheswar, Mishra, Sarbani, Jena, Chitranjali, Patra, Manaswini, Mishra, Neeraj K, Samanta, Luna, Mallick, Bairagi C
• Format: Article
• Language: English
• ISSN: 1538-0254
• DOI: 10.1080/07391102.2024.2313158

This study was conducted to test the efficacy of 5-fluorouracil (5-FU) as an anticancer drug against the human pyruvate kinase isozyme M2 (PKM2) using spectroscopic, molecular docking and molecular dynamic simulation studies. PKM2 fluorescence quenching studies in the presence of 5-FU performed at three different temperatures indicates dynamic quenching processes with single-set of binding (  ≈ 1) profile. The biomolecular quenching constants ( ) and the effective binding constants ( ) obtained are shown to increase with temperature. The calculated enthalpy (ΔH) and entropy changes (ΔS) are estimated to be -118.06 kJ/mol and 146.14 kJ/mol/K respectively, which suggest the possible mode of interaction as electrostatic and hydrogen bonding. Further, these values were used to estimate the free energy changes (ΔG) and that increases with temperature. The negative ΔG values clearly indicates spontaneous binding process that stabilizes the complex formed between 5-FU and PKM2. Far-UV CD spectra of PKM2 in the presence of 5-FU shows decrease in α-helix contents which point towards the destabilization of secondary structure that weakens the biological activity of PKM2. The intrinsic fluorescence study and circular dichroism (CD) spectra showed minor conformational changes of PKM2 in the presence of 5-FU. Additionally, the results obtained from molecular docking and all-atom molecular dynamic simulation study supports the insight of the spectroscopic binding studies, and strengthens the dynamic stability of the complex between 5-FU and PKM2 through H-bonding. This study establishes a paradigm of 5-FU-PKM2 complexation and the efficacy of 5-FU that compromises the biological activity of the targeted PKM2.Communicated by Ramaswamy H. Sarma.